DDAH1 and metabolic syndrome: Given that loss-of-function polymorphism of Ddah1 promoter was associated with increased susceptibility to metabolic syndrome (MS)13, we asked whether ADMA level and Ddah1 promoter polymorphism were associated with the bone mineral density (BMD) in humans.